Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-07ACET144OrbiMed Israel Partners Limited Partnership plan to sell securities of Adicet Bio, Inc. under Form 144MEDIUM
OrbiMed Israel Partners Limited Partnership filed Form 144 to notify SEC of plan to sell 64242 units of Adicet Bio, Inc. securities around 2026-04-07, with aggregate market value of $413,076.06. The total outstanding units is 9596407.0. The amount planned to be sold represents 0.67% of total outstanding units; ...
Micro CapBiotechnology
2026-04-07CORT144Guyer William plan to sell securities of CORCEPT THERAPEUTICS INC under Form 144MEDIUM
Guyer William filed Form 144 to notify SEC of plan to sell 20000 units of CORCEPT THERAPEUTICS INC securities around 2026-04-07, with aggregate market value of $817,000.00. The total outstanding units is 106370000.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past ...
Mid CapBiotechnology
2026-04-07CYTK144FADY MALIK plan to sell securities of CYTOKINETICS, INCORPORATED under Form 144MEDIUM
FADY MALIK filed Form 144 to notify SEC of plan to sell 22000 units of CYTOKINETICS, INCORPORATED securities around 2026-04-07, with aggregate market value of $1,428,680.00. The total outstanding units is 123162807.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past...
Mid CapBiotechnology
2026-04-07CORCEPT THERAPEUTICS INC144Guyer William plan to sell securities of CORCEPT THERAPEUTICS INC under Form 144DuplicateMEDIUM
Guyer William filed Form 144 to notify SEC of plan to sell 20000 units of CORCEPT THERAPEUTICS INC securities around 2026-04-07, with aggregate market value of $817,000.00. The total outstanding units is 106370000.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past ...
Mid CapBiotechnology
2026-04-07KYTX144DANIEL SPIEGELMAN plan to sell securities of KYVERNA THERAPEUTICS, INC. under Form 144MEDIUM
DANIEL SPIEGELMAN filed Form 144 to notify SEC of plan to sell 17578 units of KYVERNA THERAPEUTICS, INC. securities around 2026-04-07, with aggregate market value of $162,636.93. The total outstanding units is 60439893.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in ...
Small CapBiotechnology
2026-04-07CYTOKINETICS INC144FADY MALIK plan to sell securities of CYTOKINETICS, INCORPORATED under Form 144DuplicateMEDIUM
FADY MALIK filed Form 144 to notify SEC of plan to sell 22000 units of CYTOKINETICS, INCORPORATED securities around 2026-04-07, with aggregate market value of $1,428,680.00. The total outstanding units is 123162807.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past...
Mid CapBiotechnology